Ausdal Financial Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,474
Closed -$216K 323
2019
Q1
$216K Buy
+1,474
New +$214K 0.09% 240
2018
Q4
Sell
-1,750
Closed -$333K 423
2018
Q3
$333K Sell
1,750
-35
-2% -$6.43K 0.09% 257
2018
Q2
$298K Sell
1,785
-12
-0.7% -$1.93K 0.09% 279
2018
Q1
$302K Sell
1,797
-103
-5% -$17.3K 0.1% 245
2017
Q4
$311K Buy
1,900
+765
+67% +$137K 0.11% 245
2017
Q3
$233K Sell
1,135
-160
-12% -$37.2K 0.09% 284
2017
Q2
$315K Buy
1,295
+74
+6% +$17.4K 0.13% 209
2017
Q1
$292K Buy
1,221
+131
+12% +$30.5K 0.13% 199
2016
Q4
$229K Buy
+1,090
New +$226K 0.11% 216
2016
Q1
Sell
-672
Closed -$210K 1143
2015
Q4
$210K Buy
+672
New +$200K 0.11% 200

Other funds holding AGN

Ausdal Financial Partners's AGN Position: Q2 2019 in Review

Ausdal Financial Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,474 shares — an estimated $216K sold.

Ausdal Financial Partners first reported a position in AGN in Q4 2015 and held it in 10 quarters. The position peaked at $333K in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Ausdal Financial Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Ausdal Financial Partners sold 1,474 Allergan plc shares in Q2 2019, an estimated $216K.
  • Ausdal Financial Partners first reported a position in Allergan plc in Q4 2015 and held it in 10 quarters.
  • Ausdal Financial Partners's Allergan plc position peaked at $333K in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Ausdal Financial Partners's 13F filing for Q2 2019, filed 5 Aug 2019.